SOCS3 deficiency promotes M1 macrophage polarization and inflammation

Hongwei Qin1, Andrew T Holdbrooks, Yudong Liu

  • 1Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. hqin@uab.edu

Insights

Suppressors of cytokine signaling 3 (SOCS3) protein limits the M1 proinflammatory macrophage phenotype. Loss of SOCS3 in myeloid cells enhances M1 polarization and exacerbates sepsis, indicating SOCS3

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Macrophages exhibit diverse phenotypes, including M1 (proinflammatory) and M2 (anti-inflammatory), influenced by cytokines.
  • Suppressors of cytokine signaling (SOCS) proteins are key negative regulators of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling.
  • SOCS proteins are crucial for terminating innate and adaptive immune responses.

Purpose of the Study:

  • To investigate the role of SOCS3 in regulating macrophage polarization and function.
  • To determine the impact of SOCS3 deficiency on M1 macrophage activation and inflammatory responses.

Main Methods:

  • Utilized LysMCre-SOCS3(fl/fl) mice lacking SOCS3 in myeloid lineage cells.
  • Analyzed JAK/STAT pathway activation, M1 gene expression (IL-1β, IL-6, IL-12, IL-23, iNOS), and chromatin modifications.
  • Assessed the capacity of SOCS3-deficient M1 macrophages to induce Th1 and Th17 cell differentiation.
  • Evaluated the effect of SOCS3 deficiency on lipopolysaccharide (LPS)-induced sepsis severity.

Main Results:

  • Macrophages lacking SOCS3 showed enhanced and prolonged JAK/STAT pathway activation.
  • SOCS3-deficient macrophages exhibited increased M1 gene expression and chromatin modifications.
  • SOCS3-deficient M1 macrophages displayed a heightened ability to induce Th1 and Th17 cell differentiation.
  • LPS-induced sepsis was more severe in mice lacking SOCS3, with elevated M1 cytokine/chemokine levels.

Conclusions:

  • SOCS3 plays a critical role in suppressing the M1 proinflammatory macrophage phenotype.
  • SOCS3 acts as a negative regulator of inflammatory responses in macrophages.
  • Targeting SOCS3 may offer therapeutic strategies for modulating inflammatory diseases.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammation01:38

Inflammation

Overview